Jill Thuston
Psychiatric/Mental Health · Fort Gratiot, MINPI 1679088850
Payments from drug & device makers
Across 238 payments — averaging $14.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$965
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$407
- Alkermes, Inc.$333
- Otsuka America Pharmaceutical, Inc.$281
- Teva Pharmaceuticals USA, Inc.$272
- Lundbeck LLC$211
- plus $995 from 14 others
What the payments were for
- Food & beverage$3,465100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 101 | $965 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $407 |
| Alkermes, Inc. | 21 | $333 |
| Otsuka America Pharmaceutical, Inc. | 13 | $281 |
| Teva Pharmaceuticals USA, Inc. | 14 | $272 |
| Lundbeck LLC | 13 | $211 |
| Vanda Pharmaceuticals Inc. | 5 | $142 |
| E.r. Squibb & Sons, L.L.C. | 7 | $136 |
| Corium, LLC | 9 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $118 |
| Neurocrine Biosciences, Inc. | 4 | $101 |
| Johnson & Johnson | 5 | $91 |
| Axsome Therapeutics, Inc. | 4 | $61 |
| Collegium Pharmaceutical, Inc. | 2 | $49 |
| Supernus Pharmaceuticals, Inc. | 2 | $48 |
| Tris Pharma Inc | 3 | $48 |
| Indivior Inc. | 2 | $33 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$3,465 in reported general payments places this provider in the 80th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 15 | $21,982 |
| Aripiprazole | 39 | $7,203 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $2,728 |
| Duloxetine Hcl | 98 | $2,448 |
| Clonazepam | 109 | $2,141 |
| Oxcarbazepine | 21 | $1,641 |
| Buspirone Hcl | 39 | $1,380 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 31 | $1,143 |
| Gabapentin | 77 | $1,060 |
| Quetiapine Fumarate | 89 | $1,045 |
| Sertraline Hcl | 70 | $951 |
| Lamotrigine | 71 | $941 |
| Trazodone Hcl | 51 | $895 |
| Mirtazapine | 34 | $815 |
| LoxapineLoxapine Succinate | 14 | $619 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $965 | $21,98215 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $272 | $61914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 638 psychiatric/mental health providers in Michigan.
Other psychiatric/mental health in Fort Gratiot
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
- Cynthia MaiSaginaw$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.